Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update
Journal of Clinical Oncology | Feb 13, 2019
Phase I dose-escalation study of once weekly or once every two weeks administration of high-dose sunitinib in patients with refractory solid tumors
Journal of Clinical Oncology | Feb 13, 2019
Neoadjuvant degarelix vs triptorelin in premenopausal patients who receive letrozole for locally advanced endocrine-responsive breast cancer: A randomized phase II trial
Journal of Clinical Oncology | Feb 13, 2019
|Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy
Journal of Clinical Oncology | Feb 13, 2019